Literature DB >> 10419587

Oestrogen receptor and its potential role in breast cancer development.

R A Walker.   

Abstract

The first studies of oestrogen receptor (ER) focused on measurements of levels in breast cancers and relationship to hormonal response, but the introduction of antibodies which can be used on fixed tissue has meant that ER can be studied in detail in normal and precancerous tissue. Cloning and sequencing of ER has resulted in more detailed understanding of structure and function, with the identification of variant forms in both tumours and normal, followed by the discovery that ER has two forms, the classical ER-alpha and ER-beta. Analyses of both forms in normal and preneoplastic breast will be important for our understanding of the role of ER in the development of breast cancer and its possible prevention. Copyright 1999 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10419587     DOI: 10.1002/(SICI)1096-9896(199907)188:3<229::AID-PATH341>3.0.CO;2-F

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  3 in total

Review 1.  The biomedical disciplines and the structure of biomedical and clinical knowledge.

Authors:  H Nederbragt
Journal:  Theor Med Bioeth       Date:  2000-11

2.  Clinicopathological characteristics of estrogen receptor-beta-positive human breast cancers.

Authors:  Y Miyoshi; T Taguchi; J A Gustafsson; S Noguchi
Journal:  Jpn J Cancer Res       Date:  2001-10

3.  Emodin and Aloe-Emodin Suppress Breast Cancer Cell Proliferation through ER α Inhibition.

Authors:  Pao-Hsuan Huang; Chih-Yang Huang; Mei-Chih Chen; Yueh-Tsung Lee; Chia-Herng Yue; Hsin-Yi Wang; Ho Lin
Journal:  Evid Based Complement Alternat Med       Date:  2013-06-24       Impact factor: 2.629

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.